Sentinel Lymph Node Gene Expression Signature Predicts Recurrence-Free Survival in Cutaneous Melanoma
Authors:
- Lilit KarapetyanLKLilit Karapetyan
- William GoodingWGWilliam Gooding
- Aofei LiALAofei Li
- Xi YangXYXi Yang
- Andrew KnightAKAndrew Knight
- Hassan M. AbushukairHAHassan M. Abushukair
- Danielle Vargas De StefanoDSDanielle Vargas De Stefano
- Cindy SanderCSCindy Sander
- Arivarasan KarunamurthyAKArivarasan Karunamurthy
- Monica PanelliMPMonica Panelli
- Walter J. StorkusWalter J. Storkus
- Ahmad A. TarhiniATAhmad A. Tarhini
Open Access
Abstract
We sought to develop a sentinel lymph node gene expression signature score predictive of disease recurrence in patients with cutaneous melanoma. Gene expression profiling was performed on SLN biopsies using U133A 2.0 Affymetrix gene chips. The top 25 genes associated with recurrence-free survival (RFS) were selected and a penalized regression function was used to select 12 genes with a non-zero coefficient. A proportional hazards regression model was used to evaluate the association between clinical covariates, gene signature score, and RFS. Among the 45 patients evaluated, 23 (51%) had a positive SLN. Twenty-one (46.7%) patients developed disease recurrence. For the top 25 differentially expressed genes (DEG), 12 non-zero penalized coefficients were estimated (CLGN, C1QTNF3, ADORA3, ARHGAP8, DCTN1, ASPSCR1, CHRFAM7A, ZNF223, PDE6G, CXCL3, HEXIM1, HLA-DRB). This 12-gene signature score was significantly associated with RFS (p < 0.0001) and produced a bootstrap C index of 0.888. In univariate analysis, Breslow thickness, presence of primary tumor ulceration, SLN positivity were each significantly associated with RFS. After simultaneously adjusting for these prognostic factors in relation to the gene signature, the 12-gene score remained a significant independent predictor for RFS (p < 0.0001). This SLN 12-gene signature risk score is associated with melanoma recurrence regardless of SLN status and may be used as a prognostic factor for RFS.Keywords
Funding Information
- Merck (P30CA04790)
- National Cancer Institute Cancer Center Support (P30CA04790)
This publication has 59 references indexed in Scilit:
- Autosomal-Recessive Early-Onset Retinitis Pigmentosa Caused by a Mutation in PDE6G, the Gene Encoding the Gamma Subunit of Rod cGMP PhosphodiesteraseThe American Journal of Human Genetics, 2010
- Microarray analysis of normal cervix, carcinoma in situ, and invasive cervical cancer: identification of candidate genes in pathogenesis of invasion in cervical cancerInternational Journal of Gynecological Cancer, 2008
- HEXIM1 and the Control of Transcription Elongation: From Cancer and Inflammation to AIDS and Cardiac HypertrophyCell Cycle, 2007
- The Glucose Transporter 4-regulating Protein TUG Is Essential for Highly Insulin-responsive Glucose Uptake in 3T3-L1 AdipocytesJournal of Biological Chemistry, 2007
- Sentinel-Node Biopsy or Nodal Observation in MelanomaNew England Journal of Medicine, 2006
- Tumour–induced immune modulation of sentinel lymph nodesNature Reviews Immunology, 2006
- DYNACTINAnnual Review of Cell and Developmental Biology, 2004
- Expression of A3 Adenosine Receptors in Human Lymphocytes: Up-Regulation in T Cell ActivationMolecular Pharmacology, 2004
- Sentinel Lymph Node Biopsy for Head and Neck MelanomasAnnals of Surgical Oncology, 2003
- Technical Details of Intraoperative Lymphatic Mapping for Early Stage MelanomaArchives of Surgery, 1992